U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07374978) titled 'Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk' on Sept. 26, 2025.
Brief Summary: The aim of investigators was to study the effect and safety of Thrombolysis in Intermediate high risk pulmonary embolism patients with low bleeding risk as regards Mortality and bleeding events.
Study Start Date: July 01, 2023
Study Type: INTERVENTIONAL
Condition:
Pulmonary Embolism Subacute Massive
Thrombolytic Therapy
Intervention:
DRUG: Thrombolytic therapy for the study group in the form of streptokinase or recombinant tissue plasminogen activator
Thrombolytic therapy acting on ...